Plain-English translation of NCT07528781 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This research study is looking for a better way to measure and understand mitral valve leakage โ a condition where blood leaks backward through one of your heart's main valves. Doctors will use two types of imaging (a special ultrasound called transesophageal echocardiography and an MRI scan) to compare how well each method can measure the amount of leakage. The goal is to help doctors diagnose and plan the best treatment for patients like you with moderate to severe mitral regurgitation.
Currently, doctors rely on standard ultrasound to measure valve leakage, but it's not always precise. This trial exists to see if a newer, three-dimensional ultrasound technique can give doctors a clearer picture of exactly how much leakage is happening and what's causing it โ so they can recommend the right treatment, whether that's surgery or less invasive procedures.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, you will undergo two imaging tests: a transesophageal echocardiogram (where a small ultrasound probe is gently passed down your throat to get detailed pictures of your heart valve) and a cardiac MRI scan. These tests will help researchers compare how accurately each imaging method measures your valve leakage. The study is recruiting 200 patients total, and your participation will directly help doctors develop better diagnostic tools for patients with mitral valve disease.
AI-generated summary from trial data ยท Jun 5, 2026 ยท Not medical advice
Spain